Bayer announced that it acquired the rights to work with Bicycle Therapeutics (BCYC.O) on the British biotech firm’s radiotherapy cancer drug candidates.
Tag Archive for: Bicycle Therapeutics
The companies have reached a deal to discover and develop several targeted radioligand therapies in oncology.
Versant Ventures-backed Belharra Therapeutics launched Wednesday with $130 million in total financing to advance its novel chemoproteomics platform.
Roche acquired privately held Good Therapeutics and its immuno-oncology platforms for $250 million, plus future milestone payments, on Wednesday.
Genentech has signed an exclusive worldwide license agreement with Chinese pharmaceutical firm Jemincare to allow the latter to develop and commercialize JMKX002992, an androgen receptor degrader being developed for prostate cancer.
